Rite Aid Corp., the third-largest U.S. drugstore chain, reduced its sales forecast for the year, sending the shares down as much as 11 percent.
Sales will amount to as much as $25.4 billion, the Camp Hill, Pennsylvania-based company said today in a statement. That compared with a previous top target of $25.6 billion. The company also posted a wider second-quarter loss than analysts projected.
Sales fell 2.5 percent in the quarter ended Aug. 28, hurt by a “sluggish economy,” Rite Aid said. The chain, led by Chief Executive Officer John Standley, has more than 4,700 stores across the U.S.
Rite Aid fell 15 cents, or 14 percent, to 95 cents at 4:10 p.m. in New York Stock Exchange composite trading. The shares have fallen 37 percent this year.
The second-quarter loss widened to $199.3 million, or 23 cents a share, from $120.4 million, or 14 cents, a year earlier. Analysts on average projected 16 cents.